These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1450226)

  • 1. Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastases of breast cancer.
    Crippa F; Bombardieri E; Seregni E; Castellani MR; Gasparini M; Maffioli L; Pizzichetta M; Buraggi GL
    J Nucl Biol Med (1991); 1992; 36(1):52-5. PubMed ID: 1450226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between bone scintigraphy and serum levels of tumor markers in the detection of bone disease in breast cancer patients.
    Zissimopoulos A; Matthaios D; Matthaiou E; Mantadakis E; Karaitianos I
    J BUON; 2007; 12(4):505-11. PubMed ID: 18067209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy.
    Zissimopoulos A; Stellos K; Matthaios D; Petrakis G; Parmenopoulou V; Babatsikou F; Matthaiou E; Theodosiadou E; Hountis P; Koutis C
    J BUON; 2009; 14(3):463-72. PubMed ID: 19810140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone marrow scintigraphy using radiocolloids in bone metastases. Sensitivity, specificity, reliability and indications].
    Fritz P; Adolph J; Bubeck B; Georgi P; zum Winkel K
    Rofo; 1986 Jun; 144(6):689-95. PubMed ID: 3012705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reliability of CA 15-3 in the follow up of female patients with breast carcinoma and bone metastases].
    del Rocío Estrada-Sánchez G; Mireles Enríquez M; Valverde Castañeda N
    Rev Invest Clin; 2003; 55(4):412-8. PubMed ID: 14635605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
    Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
    BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of bone marrow scintigraphy in patients with recurrent breast cancer].
    Langer SW; Kamby C; Thomsen HS; Sørensen T; Hvid-Jacobsen K; Dombernowsky P; Nielsen SL
    Ugeskr Laeger; 1993 Mar; 155(11):778-82. PubMed ID: 8460428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of bone scintigraphy and tumor marker-Ca 15-3 in detection of bone metastases in patients with breast cancer.
    Begić A; Kucukalić-Selimović E; Obralić N; Durić O; Lacević N; Begović S; Dzubur-Aganović M
    Bosn J Basic Med Sci; 2005 Feb; 5(1):23-6. PubMed ID: 15771599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone scintigraphy in breast cancer: a ten-year follow-up study.
    Crippa F; Seregni E; Agresti R; Bombardieri E; Buraggi GL
    J Nucl Biol Med (1991); 1993 Jun; 37(2):57-61. PubMed ID: 8373834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between bone scintigraphy and tumor markers in patients with breast carcinoma.
    Begić A; Kucukalić-Selimović E; Obralić N; Durić O; Lacević N; Skopljak A
    Bosn J Basic Med Sci; 2006 Feb; 6(1):75-7. PubMed ID: 16533185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of skeletal metastases by serum tumor markers].
    Shinozaki T; Chigira M
    Nihon Seikeigeka Gakkai Zasshi; 1991 Aug; 65(8):441-6. PubMed ID: 1720162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy.
    Nicolini A; Ferrari P; Sagripanti A; Carpi A
    Br J Cancer; 1999 Mar; 79(9-10):1443-7. PubMed ID: 10188888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of combination of bone scanning and measurement of carcinoembryonic antigen in diagnosis of breast cancer metastases.
    Kausitz J; Makaiová I; Hupka S; Vivodová M
    Czech Med; 1981; 4(3):159-62. PubMed ID: 7307849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Scintigraphy in staging upper aerodigestive tract epidermoid carcinomas].
    Ayache S; Tramier B; Moullard V; Michel L; Strunski V
    Ann Otolaryngol Chir Cervicofac; 2008 Nov; 125(5):250-5. PubMed ID: 18789430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of skeletal scintigraphy in the follow-up of breast cancer].
    Langhammer HR; Sondershaus S; Lauer O; Steuer G; Bauer R
    Fortschr Med; 1983 Mar; 101(10):429-34. PubMed ID: 6840646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Skeletal scintigraphy in the care of breast cancer . Long-term follow-up over 8 years].
    Anger K; Möller T; Zeimantz E
    Strahlentherapie; 1983 Dec; 159(12):745-50. PubMed ID: 6665812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCA serum determination in breast carcinoma patients for the diagnosis of bone metastases.
    Dominguez-Gadea L; Martin-Curto LM; Crespo A; Avila C
    Int J Biol Markers; 1993; 8(4):203-7. PubMed ID: 8138659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bone scanning and CA 15-3 serum concentration in the follow-up of breast cancer.
    Montravers F; Younsi N; Rousseau C; Philippe C; Seddiki M; Uzan S; Izrael V; Talbot JN
    Anticancer Res; 1997; 17(3B):1683-6. PubMed ID: 9179218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.